Pfizer Inc.
PFE
$25.95
$0.160.62%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -17.70% | 5.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.69% | 5.42% | |||
| Cost of Revenue | -32.73% | 27.29% | |||
| Gross Profit | -11.59% | -1.44% | |||
| SG&A Expenses | -23.96% | 21.07% | |||
| Depreciation & Amortization | -3.82% | 0.57% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.99% | 23.88% | |||
| Operating Income | 8.68% | -28.44% | |||
| Income Before Tax | 293.00% | -149.25% | |||
| Income Tax Expenses | 23,150.00% | 99.07% | |||
| Earnings from Continuing Operations | 265.12% | -146.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 11.11% | |||
| Net Income | 263.05% | -146.54% | |||
| EBIT | 8.68% | -28.44% | |||
| EBITDA | 5.37% | -22.16% | |||
| EPS Basic | 262.91% | -146.52% | |||
| Normalized Basic EPS | -18.95% | -8.11% | |||
| EPS Diluted | 261.00% | -146.85% | |||
| Normalized Diluted EPS | -19.52% | -7.64% | |||
| Average Basic Shares Outstanding | 0.09% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.79% | -0.49% | |||
| Dividend Per Share | -50.00% | 100.00% | |||
| Payout Ratio | 1.61% | -3.15% | |||